METTL3 and thyroid gland carcinoma: MiR-21-5p is a tumorigenic miRNA targeting KLF3, YOD1, and METTL3, thus promoting pancreatic, hepatocarcinoma, and thyroid cancer progression and inducing chemoresistance (26, 121, 157).